VYGR R&D to Revenue
Voyager Therapeutics Inc · R&D to Revenue
VYGR R&D to Revenue
Latest reported696.40%period ending
VYGR Quarterly R&D/Revenue (0.00% → 696.40%)
Latest values, visible window
High-resolution chart · PNG
VYGR r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 696.3981% | |
| 948.7852% | |
| 234.4288% | |
| 268.3577% | |
| 602.5% | |
| 487.0385% | |
| 566.7888% | |
| 122.7861% | |
| 116.4785% | |
| 132.6911% | |
| 27.1161% | |
| 560.5332% | |
| 453.0188% | |
| 12.3392% | |
| -938.7742% | |
| 47.0647% | |
| 1,759.4101% | |
| 2,180.6991% | |
| 49.9412% | |
| 1,208.7719% | |
| 1,437.3618% | |
| 343.7317% | |
| 336.4846% | |
| 21.2478% | |
| 102.5871% | |
| 178.7458% | |
| 111.8657% | |
| 145.7299% | |
| 62.0045% | |
| 477.7949% | |
| 842.3307% | |
| 794.2693% | |
| 641.0485% | |
| 1,576.7516% | |
| 210.0394% | |
| 1,703.9199% | |
| 1,299.915% | |
| 961.2022% | |
| 538.6537% | |
| 311.6385% | |
| 281.828% | |
| 180.7867% | |
| 186.7531% | |
| 131.2741% | |
| 132.1663% | |
| 214.4022% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |